A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.
Mol Genet Metab
; 96(4): 164-70, 2009 Apr.
Article
en En
| MEDLINE
| ID: mdl-19195916
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Gaucher
/
Glucosilceramidasa
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2009
Tipo del documento:
Article